In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?

In this paper we have investigated the behavior of core-shell poly(ethylene oxide)-poly(epsilon-caprolactone) (PEO-PCL) micelles derived from copolymers with linear triblock (TR) and 4-arm star-diblock (ST) architectures for the delivery of docetaxel (DTX). DTX was loaded inside micelles (DTX-TR m a...

Full description

Saved in:
Bibliographic Details
Published inJournal of controlled release Vol. 148; no. 2; pp. 255 - 263
Main Authors Ostacolo, Luisanna, Marra, Monica, Ungaro, Francesca, Zappavigna, Silvia, Maglio, Giovanni, Quaglia, Fabiana, Abbruzzese, Alberto, Caraglia, Michele
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier B.V 01.12.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In this paper we have investigated the behavior of core-shell poly(ethylene oxide)-poly(epsilon-caprolactone) (PEO-PCL) micelles derived from copolymers with linear triblock (TR) and 4-arm star-diblock (ST) architectures for the delivery of docetaxel (DTX). DTX was loaded inside micelles (DTX-TR m and DTX-ST m) with high efficiency and released slowly for more than two weeks. DTX-loaded micelles based on both copolymers had very similar properties in terms of mean size, zeta potential, loading ability and release rate in buffered saline. However, the stability of DTX-ST m was very poor in aqueous media with proteins resulting in a strong and progressive aggregation. We studied the effect of increasing concentrations of free DTX or DTX-loaded micelles on growth inhibition of human breast MCF-7 and MDA-MB468 and prostate PC3 and DU145 adenocarcinoma cell lines. DTX-loaded TR micelles induced cell growth inhibition similarly to free DTX whereas DTX-ST m showed lower cytotoxicity. On the other hand, by normalizing IC 50 values for the actual amount of DTX released from micelles in the medium, DTX-loaded ST micelles became more active than free DTX in all cell lines tested. Both free DTX and DTX-loaded TR micelles displayed a significantly lower cytotoxic activity in G 2/M phase synchronized cells, whereas cytotoxicity of DTX-loaded ST micelles did not change. Cytotoxicity was related to micelle stability, uptake and release rate in cell culture media. Our results suggest that for a correct interpretation of cytotoxicity of nanocarriers, the evaluation of their behavior in biologically relevant conditions is of utmost importance to select proper systems for further in vivo testing. Biodegradable micelles delivering an anticancer drug and made of poly(ethylene oxide)/poly(epsilon-caprolactone) block copolymers with different architectures share similar technological features while showing very different cytotoxicity. [Display omitted]
AbstractList In this paper we have investigated the behavior of core-shell poly(ethylene oxide)-poly(epsilon-caprolactone) (PEO-PCL) micelles derived from copolymers with linear triblock (TR) and 4-arm star-diblock (ST) architectures for the delivery of docetaxel (DTX). DTX was loaded inside micelles (DTX-TR m and DTX-ST m) with high efficiency and released slowly for more than two weeks. DTX-loaded micelles based on both copolymers had very similar properties in terms of mean size, zeta potential, loading ability and release rate in buffered saline. However, the stability of DTX-ST m was very poor in aqueous media with proteins resulting in a strong and progressive aggregation. We studied the effect of increasing concentrations of free DTX or DTX-loaded micelles on growth inhibition of human breast MCF-7 and MDA-MB468 and prostate PC3 and DU145 adenocarcinoma cell lines. DTX-loaded TR micelles induced cell growth inhibition similarly to free DTX whereas DTX-ST m showed lower cytotoxicity. On the other hand, by normalizing IC 50 values for the actual amount of DTX released from micelles in the medium, DTX-loaded ST micelles became more active than free DTX in all cell lines tested. Both free DTX and DTX-loaded TR micelles displayed a significantly lower cytotoxic activity in G 2/M phase synchronized cells, whereas cytotoxicity of DTX-loaded ST micelles did not change. Cytotoxicity was related to micelle stability, uptake and release rate in cell culture media. Our results suggest that for a correct interpretation of cytotoxicity of nanocarriers, the evaluation of their behavior in biologically relevant conditions is of utmost importance to select proper systems for further in vivo testing. Biodegradable micelles delivering an anticancer drug and made of poly(ethylene oxide)/poly(epsilon-caprolactone) block copolymers with different architectures share similar technological features while showing very different cytotoxicity. [Display omitted]
In this paper we have investigated the behavior of core-shell poly(ethylene oxide)-poly(epsilon-caprolactone) (PEO-PCL) micelles derived from copolymers with linear triblock (TR) and 4-arm star-diblock (ST) architectures for the delivery of docetaxel (DTX). DTX was loaded inside micelles (DTX-TR sub(m) and DTX-ST sub(m)) with high efficiency and released slowly for more than two weeks. DTX-loaded micelles based on both copolymers had very similar properties in terms of mean size, zeta potential, loading ability and release rate in buffered saline. However, the stability of DTX-ST sub(m) was very poor in aqueous media with proteins resulting in a strong and progressive aggregation. We studied the effect of increasing concentrations of free DTX or DTX-loaded micelles on growth inhibition of human breast MCF-7 and MDA-MB468 and prostate PC3 and DU145 adenocarcinoma cell lines. DTX-loaded TR micelles induced cell growth inhibition similarly to free DTX whereas DTX-ST sub(m) showed lower cytotoxicity. On the other hand, by normalizing IC sub(50) values for the actual amount of DTX released from micelles in the medium, DTX-loaded ST micelles became more active than free DTX in all cell lines tested. Both free DTX and DTX-loaded TR micelles displayed a significantly lower cytotoxic activity in G sub(2)/M phase synchronized cells, whereas cytotoxicity of DTX-loaded ST micelles did not change. Cytotoxicity was related to micelle stability, uptake and release rate in cell culture media. Our results suggest that for a correct interpretation of cytotoxicity of nanocarriers, the evaluation of their behavior in biologically relevant conditions is of utmost importance to select proper systems for further in vivo testing.
In this paper we have investigated the behavior of core-shell poly(ethylene oxide)-poly(epsilon-caprolactone) (PEO-PCL) micelles derived from copolymers with linear triblock (TR) and 4-arm star-diblock (ST) architectures for the delivery of docetaxel (DTX). DTX was loaded inside micelles (DTX-TR(m) and DTX-ST(m)) with high efficiency and released slowly for more than two weeks. DTX-loaded micelles based on both copolymers had very similar properties in terms of mean size, zeta potential, loading ability and release rate in buffered saline. However, the stability of DTX-ST(m) was very poor in aqueous media with proteins resulting in a strong and progressive aggregation. We studied the effect of increasing concentrations of free DTX or DTX-loaded micelles on growth inhibition of human breast MCF-7 and MDA-MB468 and prostate PC3 and DU145 adenocarcinoma cell lines. DTX-loaded TR micelles induced cell growth inhibition similarly to free DTX whereas DTX-ST(m) showed lower cytotoxicity. On the other hand, by normalizing IC(50) values for the actual amount of DTX released from micelles in the medium, DTX-loaded ST micelles became more active than free DTX in all cell lines tested. Both free DTX and DTX-loaded TR micelles displayed a significantly lower cytotoxic activity in G(2)/M phase synchronized cells, whereas cytotoxicity of DTX-loaded ST micelles did not change. Cytotoxicity was related to micelle stability, uptake and release rate in cell culture media. Our results suggest that for a correct interpretation of cytotoxicity of nanocarriers, the evaluation of their behavior in biologically relevant conditions is of utmost importance to select proper systems for further in vivo testing.
Author Ungaro, Francesca
Zappavigna, Silvia
Abbruzzese, Alberto
Caraglia, Michele
Maglio, Giovanni
Ostacolo, Luisanna
Marra, Monica
Quaglia, Fabiana
Author_xml – sequence: 1
  givenname: Luisanna
  surname: Ostacolo
  fullname: Ostacolo, Luisanna
  organization: Department of Pharmaceutical and Toxicological Chemistry, University of Naples Federico II, Via D. Montesano 49, 80131, Naples – Italy
– sequence: 2
  givenname: Monica
  surname: Marra
  fullname: Marra, Monica
  organization: Department of Biochemistry and Biophysics, II University of Naples, Via Costantinopoli 16, 80138, Naples – Italy
– sequence: 3
  givenname: Francesca
  surname: Ungaro
  fullname: Ungaro, Francesca
  organization: Department of Pharmaceutical and Toxicological Chemistry, University of Naples Federico II, Via D. Montesano 49, 80131, Naples – Italy
– sequence: 4
  givenname: Silvia
  surname: Zappavigna
  fullname: Zappavigna, Silvia
  organization: Department of Biochemistry and Biophysics, II University of Naples, Via Costantinopoli 16, 80138, Naples – Italy
– sequence: 5
  givenname: Giovanni
  surname: Maglio
  fullname: Maglio, Giovanni
  organization: Department of Chemistry “Paolo Corradini”, University of Naples Federico II, Via Cintia, 80126, Naples – Italy
– sequence: 6
  givenname: Fabiana
  surname: Quaglia
  fullname: Quaglia, Fabiana
  email: quaglia@unina.it
  organization: Department of Pharmaceutical and Toxicological Chemistry, University of Naples Federico II, Via D. Montesano 49, 80131, Naples – Italy
– sequence: 7
  givenname: Alberto
  surname: Abbruzzese
  fullname: Abbruzzese, Alberto
  organization: Department of Biochemistry and Biophysics, II University of Naples, Via Costantinopoli 16, 80138, Naples – Italy
– sequence: 8
  givenname: Michele
  surname: Caraglia
  fullname: Caraglia, Michele
  organization: Department of Biochemistry and Biophysics, II University of Naples, Via Costantinopoli 16, 80138, Naples – Italy
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23504602$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20816710$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1DAQgC1URLeFRwD5gqCHLHZiO0kvFSp_lSpxgbPl2BPVi2MHO7vqPhMvyax2gSMXWx594_n5LshZTBEIecnZmjOu3m3WG5tihrCuGcZYt2ZMPSEr3rVNJfpenpEVcl3VKNmfk4tSNowx2Yj2GTmvWcdVy9mK_LqLdOeXnKiJi7cmWsjU2MVjcE_TSF2ysJhHCFVIxoGjk7cQAhQ6mILPFOmcwv4tLA_7ABFoevQOrqpjcC4-pFhZM-cU8Fuc4YoOIdkf1KYDMkEu1_RDotHEZE3OHusjPENePBZ5MDughmI23DwnT0cTCrw43Zfk-6eP326_VPdfP9_dvr-vrKjVUkmmnOtcI0AMvQMAUfccRiVVi2druGKtrFXHezmKhtVNL5pBCuFqJxQbRHNJ3hz_xT5-bqEsevLlMLSJkLZF91LIntVCIimPpM2plAyjnrOfTN5rzvRBk97okyZ90KRZp1ET5r06VdgOE7i_WX-8IPD6BJhiTRgzivHlH9dIhr3WyN0cOcB97HB3ulgPKNH5DHbRLvn_tPIbxH24QQ
CODEN JCREEC
CitedBy_id crossref_primary_10_1002_adhm_201300519
crossref_primary_10_1016_j_nano_2011_08_012
crossref_primary_10_1016_j_jcis_2024_03_154
crossref_primary_10_1186_s12951_016_0239_0
crossref_primary_10_1002_advs_201600285
crossref_primary_10_1016_j_jconrel_2011_06_012
crossref_primary_10_3390_ma16062298
crossref_primary_10_1016_j_nano_2020_102267
crossref_primary_10_1080_1061186X_2016_1245309
crossref_primary_10_1002_pat_3556
crossref_primary_10_1016_j_progpolymsci_2015_11_002
crossref_primary_10_1016_j_ijpharm_2015_03_067
crossref_primary_10_1021_acsabm_4c00638
crossref_primary_10_1021_acsabm_8b00675
crossref_primary_10_1021_acs_biomac_1c01022
crossref_primary_10_1016_j_hsr_2023_100101
crossref_primary_10_1016_j_ijpharm_2019_118486
crossref_primary_10_1016_j_ijpharm_2023_122711
crossref_primary_10_18632_oncotarget_9771
crossref_primary_10_3390_polym15051179
crossref_primary_10_1039_C5RA21067D
crossref_primary_10_3390_molecules23020497
crossref_primary_10_1038_srep28373
crossref_primary_10_1038_srep29460
crossref_primary_10_1002_pi_4896
crossref_primary_10_1016_j_apmt_2023_101865
crossref_primary_10_1016_j_jconrel_2014_03_026
crossref_primary_10_3390_polym13183133
crossref_primary_10_1016_j_ijpharm_2015_07_012
crossref_primary_10_1016_j_ijpharm_2013_05_003
crossref_primary_10_1002_macp_201400043
crossref_primary_10_1021_acs_molpharmaceut_7b00177
crossref_primary_10_1016_j_msec_2015_12_049
crossref_primary_10_3390_polym6030634
crossref_primary_10_1016_j_biopha_2011_09_010
crossref_primary_10_1002_mabi_201100083
crossref_primary_10_1517_17425247_2012_696606
crossref_primary_10_1021_acsami_6b01611
crossref_primary_10_1016_j_progpolymsci_2015_10_009
crossref_primary_10_1016_j_ijpharm_2014_03_009
crossref_primary_10_1007_s10549_019_05301_0
crossref_primary_10_1016_j_biomaterials_2015_02_108
crossref_primary_10_1038_srep34069
crossref_primary_10_1016_j_biomaterials_2014_01_040
crossref_primary_10_1021_acsomega_7b00829
crossref_primary_10_1517_17425247_2014_913568
crossref_primary_10_1080_21691401_2017_1307214
crossref_primary_10_1002_jps_23418
crossref_primary_10_1016_j_jconrel_2012_12_026
Cites_doi 10.1634/theoncologist.10-90003-30
10.1002/jbm.a.31804
10.1016/j.jconrel.2009.11.012
10.1615/CritRevTherDrugCarrierSyst.v25.i6.10
10.1021/la0531998
10.1007/s00345-002-0275-2
10.1016/j.biomaterials.2008.09.035
10.1016/j.jconrel.2009.04.010
10.1080/15583720701455079
10.1016/j.biomaterials.2005.05.042
10.1002/jps.21037
10.1016/S0168-3659(02)00212-2
10.2174/138161206779026263
10.1016/j.ejpb.2007.08.014
10.1517/14656566.9.15.2603
10.1097/CAD.0b013e3280113338
10.1016/j.ejpb.2006.11.010
10.1021/mp800049w
10.1021/mp800137z
10.1016/j.ejpb.2007.02.024
10.1007/s10549-007-9591-y
10.1093/jb/mvg097
10.1016/0142-9612(96)85755-3
10.1016/j.biomaterials.2007.05.026
10.1016/S0169-409X(98)00100-8
10.2165/00003088-199936020-00002
10.1038/nrd2614
ContentType Journal Article
Copyright 2010 Elsevier B.V.
2015 INIST-CNRS
Copyright © 2010 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2010 Elsevier B.V.
– notice: 2015 INIST-CNRS
– notice: Copyright © 2010 Elsevier B.V. All rights reserved.
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QO
8FD
FR3
P64
DOI 10.1016/j.jconrel.2010.08.006
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList
Engineering Research Database
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-4995
EndPage 263
ExternalDocumentID 10_1016_j_jconrel_2010_08_006
20816710
23504602
S0168365910006619
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
1B1
1RT
1~.
1~5
29K
3O-
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
AABNK
AABXZ
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXUO
AAYOK
ABFNM
ABFRF
ABJNI
ABMAC
ABOCM
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACNNM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEZYN
AFKWA
AFRZQ
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CS3
D-I
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMT
HVGLF
HZ~
IHE
J1W
KOM
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
RNS
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPC
SPCBC
SPT
SSM
SSP
SSZ
T5K
TEORI
WUQ
~G-
ABPIF
ABPTK
IQODW
AAHBH
AAXKI
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
AFJKZ
CITATION
7QO
8FD
FR3
P64
ID FETCH-LOGICAL-c426t-506dd8d34e4b9deee4291ef6567ef67a16075268195f43023943b544d2d460b43
IEDL.DBID AIKHN
ISSN 0168-3659
IngestDate Sat Oct 26 01:31:58 EDT 2024
Thu Sep 26 15:43:44 EDT 2024
Sat Sep 28 07:53:44 EDT 2024
Sun Oct 22 16:09:10 EDT 2023
Fri Feb 23 02:28:55 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Poly(ethylene oxide)-poly(epsilon-caprolactone)
Cytotoxicity
Stability
Micelles
Docetaxel
Antineoplastic agent
Lactone copolymer
Pharmaceutical technology
Micelle
In vitro
Biological activity
Ethylene oxide polymer
Caprolactone copolymer
Cyclic ether polymer
Taxane derivatives
Antimitotic
Physicochemical properties
Block copolymer
Nanotechnology
Language English
License CC BY 4.0
Copyright © 2010 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c426t-506dd8d34e4b9deee4291ef6567ef67a16075268195f43023943b544d2d460b43
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 20816710
PQID 954590245
PQPubID 23462
PageCount 9
ParticipantIDs proquest_miscellaneous_954590245
crossref_primary_10_1016_j_jconrel_2010_08_006
pubmed_primary_20816710
pascalfrancis_primary_23504602
elsevier_sciencedirect_doi_10_1016_j_jconrel_2010_08_006
PublicationCentury 2000
PublicationDate 2010-12-01
PublicationDateYYYYMMDD 2010-12-01
PublicationDate_xml – month: 12
  year: 2010
  text: 2010-12-01
  day: 01
PublicationDecade 2010
PublicationPlace Kidlington
PublicationPlace_xml – name: Kidlington
– name: Netherlands
PublicationTitle Journal of controlled release
PublicationTitleAlternate J Control Release
PublicationYear 2010
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Letchford, Liggins, Burt (bb0095) 2008; 3
Gopferich (bb0100) 1996; 2
Lee, Chung, Im, Park, Kim, Kim, Rha, Lee, Ro (bb0035) 2008; 2
Quaglia, Ostacolo, Nese, Canciello, De Rosa, Ungaro, Palumbo, La Rotonda, Maglio (bb0080) 2008; 3
LiL (bb0090) 2008; 4
Petri-Fink, Steitz, Finka, Salaklang, Hofmann (bb0070) 2008; 1
Quaglia, Ostacolo, Mazzaglia, Villari, Zaccaria, Sciortino (bb0120) 2009; 3
Berry, Eisenberger (bb0055) 2005
Calabro, Sternberg (bb0045) 2002; 3
Dong, Feng (bb0115) 2007; 28
Harush-Frenkel, Altschuler, Benita (bb0135) 2008; 6
Tong, Cheng (bb0015) 2007; 3
Mikhail, Allen (bb0030) 2009; 3
Caraglia, Marra, Giuberti, D'Alessandro, Baldi, Tassone, Venuta, Tagliaferri, Abbruzzese (bb0085) 2003; 6
Carstens, de Jong, van Nostrum, Kemmink, Verrijk, de Leede, Crommelin, Hennink (bb0105) 2008; 3
Davis, Chen, Shin (bb0060) 2008; 9
Fonseca, Simoes, Gaspar (bb0125) 2002; 2
Gaucher, Leroux (bb0025) 2010
Engels, Mathot, Verweij (bb0005) 2007; 2
Aliabadi, Brocks, Lavasanifar (bb0110) 2005; 35
Xu, Gullotti, Tong, Highley, Errabelli, Hasan, Cheng, Kohane, Yeo (bb0130) 2009; 1
Liu, Zeng, Allen (bb0075) 2007; 3
Trubetskoy (bb0020) 1999; 1–3
Savic, Azzam, Eisenberg, Maysinger (bb0065) 2006; 8
Clarke, Rivory (bb0040) 1999; 2
Saloustros, Mavroudis, Georgoulias (bb0050) 2008; 15
Liu, Lee, Allen (bb0010) 2006; 36
Caraglia (10.1016/j.jconrel.2010.08.006_bb0085) 2003; 6
Savic (10.1016/j.jconrel.2010.08.006_bb0065) 2006; 8
LiL (10.1016/j.jconrel.2010.08.006_bb0090) 2008; 4
Quaglia (10.1016/j.jconrel.2010.08.006_bb0120) 2009; 3
Saloustros (10.1016/j.jconrel.2010.08.006_bb0050) 2008; 15
Davis (10.1016/j.jconrel.2010.08.006_bb0060) 2008; 9
Liu (10.1016/j.jconrel.2010.08.006_bb0010) 2006; 36
Gopferich (10.1016/j.jconrel.2010.08.006_bb0100) 1996; 2
Gaucher (10.1016/j.jconrel.2010.08.006_bb0025) 2010
Xu (10.1016/j.jconrel.2010.08.006_bb0130) 2009; 1
Dong (10.1016/j.jconrel.2010.08.006_bb0115) 2007; 28
Petri-Fink (10.1016/j.jconrel.2010.08.006_bb0070) 2008; 1
Liu (10.1016/j.jconrel.2010.08.006_bb0075) 2007; 3
Carstens (10.1016/j.jconrel.2010.08.006_bb0105) 2008; 3
Clarke (10.1016/j.jconrel.2010.08.006_bb0040) 1999; 2
Letchford (10.1016/j.jconrel.2010.08.006_bb0095) 2008; 3
Fonseca (10.1016/j.jconrel.2010.08.006_bb0125) 2002; 2
Tong (10.1016/j.jconrel.2010.08.006_bb0015) 2007; 3
Lee (10.1016/j.jconrel.2010.08.006_bb0035) 2008; 2
Engels (10.1016/j.jconrel.2010.08.006_bb0005) 2007; 2
Berry (10.1016/j.jconrel.2010.08.006_bb0055) 2005
Mikhail (10.1016/j.jconrel.2010.08.006_bb0030) 2009; 3
Aliabadi (10.1016/j.jconrel.2010.08.006_bb0110) 2005; 35
Harush-Frenkel (10.1016/j.jconrel.2010.08.006_bb0135) 2008; 6
Trubetskoy (10.1016/j.jconrel.2010.08.006_bb0020) 1999; 1–3
Calabro (10.1016/j.jconrel.2010.08.006_bb0045) 2002; 3
Quaglia (10.1016/j.jconrel.2010.08.006_bb0080) 2008; 3
References_xml – volume: 3
  start-page: 158
  year: 2002
  end-page: 166
  ident: bb0045
  article-title: New drugs and new approaches for the treatment of metastatic urothelial cancer
  publication-title: World J. Urol.
  contributor:
    fullname: Sternberg
– volume: 1
  start-page: 190
  year: 2009
  end-page: 201
  ident: bb0130
  article-title: Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited
  publication-title: Mol. Pharm.
  contributor:
    fullname: Yeo
– volume: 2
  start-page: 273
  year: 2002
  end-page: 286
  ident: bb0125
  article-title: Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity
  publication-title: J. Control. Release
  contributor:
    fullname: Gaspar
– volume: 28
  start-page: 4154
  year: 2007
  end-page: 4160
  ident: bb0115
  article-title: In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy
  publication-title: Biomaterials
  contributor:
    fullname: Feng
– volume: 2
  start-page: 241
  year: 2008
  end-page: 250
  ident: bb0035
  article-title: Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer
  publication-title: Breast Cancer Res. Treat.
  contributor:
    fullname: Ro
– volume: 3
  start-page: 1179
  year: 2008
  end-page: 1190
  ident: bb0095
  article-title: Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations
  publication-title: J. Pharm. Sci.
  contributor:
    fullname: Burt
– volume: 15
  start-page: 2603
  year: 2008
  end-page: 2616
  ident: bb0050
  article-title: Paclitaxel and docetaxel in the treatment of breast cancer
  publication-title: Expert Opin. Pharmacother.
  contributor:
    fullname: Georgoulias
– volume: 6
  start-page: 485
  year: 2008
  end-page: 544
  ident: bb0135
  article-title: Nanoparticle-cell interactions: drug delivery implications
  publication-title: Crit. Rev. Ther. Drug Carrier Syst.
  contributor:
    fullname: Benita
– volume: 2
  start-page: 103
  year: 1996
  end-page: 114
  ident: bb0100
  article-title: Mechanisms of polymer degradation and erosion
  publication-title: Biomaterials
  contributor:
    fullname: Gopferich
– volume: 3
  start-page: 214
  year: 2009
  end-page: 223
  ident: bb0030
  article-title: Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels
  publication-title: J. Control. Release
  contributor:
    fullname: Allen
– volume: 1–3
  start-page: 81
  year: 1999
  end-page: 88
  ident: bb0020
  article-title: Polymeric micelles as carriers of diagnostic agents
  publication-title: Adv. Drug Deliv. Rev.
  contributor:
    fullname: Trubetskoy
– year: 2010
  ident: bb0025
  article-title: Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes
  publication-title: J. Control. Release
  contributor:
    fullname: Leroux
– volume: 35
  start-page: 7251
  year: 2005
  end-page: 7259
  ident: bb0110
  article-title: Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution
  publication-title: Biomaterials
  contributor:
    fullname: Lavasanifar
– volume: 9
  start-page: 771
  year: 2008
  end-page: 782
  ident: bb0060
  article-title: Nanoparticle therapeutics: an emerging treatment modality for cancer
  publication-title: Nat. Rev. Drug Discov.
  contributor:
    fullname: Shin
– volume: 2
  start-page: 99
  year: 1999
  end-page: 114
  ident: bb0040
  article-title: Clinical pharmacokinetics of docetaxel
  publication-title: Clin. Pharmacokinet.
  contributor:
    fullname: Rivory
– volume: 3
  start-page: 345
  year: 2007
  end-page: 381
  ident: bb0015
  article-title: Anticancer polymeric nanomedicines
  publication-title: Polym. Rev.
  contributor:
    fullname: Cheng
– volume: 1
  start-page: 129
  year: 2008
  end-page: 137
  ident: bb0070
  article-title: Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Hofmann
– volume: 8
  start-page: 3570
  year: 2006
  end-page: 3578
  ident: bb0065
  article-title: Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: a fluorogenic-based approach
  publication-title: Langmuir
  contributor:
    fullname: Maysinger
– volume: 2
  start-page: 95
  year: 2007
  end-page: 103
  ident: bb0005
  article-title: [PEGylated (immuno)liposomal DTX, DTX-fibrinogen-coated olive oil droplets, DTX encapsulated nanoparticle-aptamer bioconjugates, submicronic dispersion formulation] to develop an alternative, solvent-free, delivery form for DTX characterized by increased efficacy and decreased toxicity. Alternative drug formulations of DTX: a review.
  publication-title: Anticancer Drugs
  contributor:
    fullname: Verweij
– volume: 3
  start-page: 596
  year: 2008
  end-page: 606
  ident: bb0105
  article-title: The effect of core composition in biodegradable oligomeric micelles as taxane formulations
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Hennink
– volume: 3
  start-page: 374
  year: 2009
  end-page: 382
  ident: bb0120
  article-title: The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs
  publication-title: Biomaterials
  contributor:
    fullname: Sciortino
– volume: 6
  start-page: 757
  year: 2003
  end-page: 765
  ident: bb0085
  article-title: The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells
  publication-title: J. Biochem.
  contributor:
    fullname: Abbruzzese
– volume: 4
  start-page: 496
  year: 2008
  end-page: 504
  ident: bb0090
  article-title: Huang, Pharmacokinetics and biodistribution of nanoparticles
  publication-title: Mol. Pharm.
  contributor:
    fullname: LiL
– volume: 3
  start-page: 563
  year: 2008
  end-page: 574
  ident: bb0080
  article-title: Micelles based on amphiphilic PCL-PEO triblock and star-shaped diblock copolymers: potential in drug delivery applications
  publication-title: J. Biomed. Mater. Res. A
  contributor:
    fullname: Maglio
– start-page: 30
  year: 2005
  end-page: 39
  ident: bb0055
  article-title: Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy
  publication-title: Oncologist
  contributor:
    fullname: Eisenberger
– volume: 3
  start-page: 309
  year: 2007
  end-page: 319
  ident: bb0075
  article-title: In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Allen
– volume: 36
  start-page: 4685
  year: 2006
  end-page: 4701
  ident: bb0010
  article-title: Formulation of drugs in block copolymer micelles: drug loading and release
  publication-title: Curr. Pharm. Des.
  contributor:
    fullname: Allen
– start-page: 30
  year: 2005
  ident: 10.1016/j.jconrel.2010.08.006_bb0055
  article-title: Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy
  publication-title: Oncologist
  doi: 10.1634/theoncologist.10-90003-30
  contributor:
    fullname: Berry
– volume: 3
  start-page: 563
  year: 2008
  ident: 10.1016/j.jconrel.2010.08.006_bb0080
  article-title: Micelles based on amphiphilic PCL-PEO triblock and star-shaped diblock copolymers: potential in drug delivery applications
  publication-title: J. Biomed. Mater. Res. A
  doi: 10.1002/jbm.a.31804
  contributor:
    fullname: Quaglia
– year: 2010
  ident: 10.1016/j.jconrel.2010.08.006_bb0025
  article-title: Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2009.11.012
  contributor:
    fullname: Gaucher
– volume: 6
  start-page: 485
  year: 2008
  ident: 10.1016/j.jconrel.2010.08.006_bb0135
  article-title: Nanoparticle-cell interactions: drug delivery implications
  publication-title: Crit. Rev. Ther. Drug Carrier Syst.
  doi: 10.1615/CritRevTherDrugCarrierSyst.v25.i6.10
  contributor:
    fullname: Harush-Frenkel
– volume: 8
  start-page: 3570
  year: 2006
  ident: 10.1016/j.jconrel.2010.08.006_bb0065
  article-title: Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: a fluorogenic-based approach
  publication-title: Langmuir
  doi: 10.1021/la0531998
  contributor:
    fullname: Savic
– volume: 3
  start-page: 158
  year: 2002
  ident: 10.1016/j.jconrel.2010.08.006_bb0045
  article-title: New drugs and new approaches for the treatment of metastatic urothelial cancer
  publication-title: World J. Urol.
  doi: 10.1007/s00345-002-0275-2
  contributor:
    fullname: Calabro
– volume: 3
  start-page: 374
  year: 2009
  ident: 10.1016/j.jconrel.2010.08.006_bb0120
  article-title: The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2008.09.035
  contributor:
    fullname: Quaglia
– volume: 3
  start-page: 214
  year: 2009
  ident: 10.1016/j.jconrel.2010.08.006_bb0030
  article-title: Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2009.04.010
  contributor:
    fullname: Mikhail
– volume: 3
  start-page: 345
  year: 2007
  ident: 10.1016/j.jconrel.2010.08.006_bb0015
  article-title: Anticancer polymeric nanomedicines
  publication-title: Polym. Rev.
  doi: 10.1080/15583720701455079
  contributor:
    fullname: Tong
– volume: 35
  start-page: 7251
  year: 2005
  ident: 10.1016/j.jconrel.2010.08.006_bb0110
  article-title: Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2005.05.042
  contributor:
    fullname: Aliabadi
– volume: 3
  start-page: 1179
  year: 2008
  ident: 10.1016/j.jconrel.2010.08.006_bb0095
  article-title: Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.21037
  contributor:
    fullname: Letchford
– volume: 2
  start-page: 273
  year: 2002
  ident: 10.1016/j.jconrel.2010.08.006_bb0125
  article-title: Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity
  publication-title: J. Control. Release
  doi: 10.1016/S0168-3659(02)00212-2
  contributor:
    fullname: Fonseca
– volume: 36
  start-page: 4685
  year: 2006
  ident: 10.1016/j.jconrel.2010.08.006_bb0010
  article-title: Formulation of drugs in block copolymer micelles: drug loading and release
  publication-title: Curr. Pharm. Des.
  doi: 10.2174/138161206779026263
  contributor:
    fullname: Liu
– volume: 3
  start-page: 596
  year: 2008
  ident: 10.1016/j.jconrel.2010.08.006_bb0105
  article-title: The effect of core composition in biodegradable oligomeric micelles as taxane formulations
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2007.08.014
  contributor:
    fullname: Carstens
– volume: 15
  start-page: 2603
  year: 2008
  ident: 10.1016/j.jconrel.2010.08.006_bb0050
  article-title: Paclitaxel and docetaxel in the treatment of breast cancer
  publication-title: Expert Opin. Pharmacother.
  doi: 10.1517/14656566.9.15.2603
  contributor:
    fullname: Saloustros
– volume: 2
  start-page: 95
  year: 2007
  ident: 10.1016/j.jconrel.2010.08.006_bb0005
  article-title: [PEGylated (immuno)liposomal DTX, DTX-fibrinogen-coated olive oil droplets, DTX encapsulated nanoparticle-aptamer bioconjugates, submicronic dispersion formulation] to develop an alternative, solvent-free, delivery form for DTX characterized by increased efficacy and decreased toxicity. Alternative drug formulations of DTX: a review.
  publication-title: Anticancer Drugs
  doi: 10.1097/CAD.0b013e3280113338
  contributor:
    fullname: Engels
– volume: 3
  start-page: 309
  year: 2007
  ident: 10.1016/j.jconrel.2010.08.006_bb0075
  article-title: In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2006.11.010
  contributor:
    fullname: Liu
– volume: 4
  start-page: 496
  year: 2008
  ident: 10.1016/j.jconrel.2010.08.006_bb0090
  article-title: Huang, Pharmacokinetics and biodistribution of nanoparticles
  publication-title: Mol. Pharm.
  doi: 10.1021/mp800049w
  contributor:
    fullname: LiL
– volume: 1
  start-page: 190
  year: 2009
  ident: 10.1016/j.jconrel.2010.08.006_bb0130
  article-title: Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited
  publication-title: Mol. Pharm.
  doi: 10.1021/mp800137z
  contributor:
    fullname: Xu
– volume: 1
  start-page: 129
  year: 2008
  ident: 10.1016/j.jconrel.2010.08.006_bb0070
  article-title: Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2007.02.024
  contributor:
    fullname: Petri-Fink
– volume: 2
  start-page: 241
  year: 2008
  ident: 10.1016/j.jconrel.2010.08.006_bb0035
  article-title: Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-007-9591-y
  contributor:
    fullname: Lee
– volume: 6
  start-page: 757
  year: 2003
  ident: 10.1016/j.jconrel.2010.08.006_bb0085
  article-title: The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells
  publication-title: J. Biochem.
  doi: 10.1093/jb/mvg097
  contributor:
    fullname: Caraglia
– volume: 2
  start-page: 103
  year: 1996
  ident: 10.1016/j.jconrel.2010.08.006_bb0100
  article-title: Mechanisms of polymer degradation and erosion
  publication-title: Biomaterials
  doi: 10.1016/0142-9612(96)85755-3
  contributor:
    fullname: Gopferich
– volume: 28
  start-page: 4154
  year: 2007
  ident: 10.1016/j.jconrel.2010.08.006_bb0115
  article-title: In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2007.05.026
  contributor:
    fullname: Dong
– volume: 1–3
  start-page: 81
  year: 1999
  ident: 10.1016/j.jconrel.2010.08.006_bb0020
  article-title: Polymeric micelles as carriers of diagnostic agents
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/S0169-409X(98)00100-8
  contributor:
    fullname: Trubetskoy
– volume: 2
  start-page: 99
  year: 1999
  ident: 10.1016/j.jconrel.2010.08.006_bb0040
  article-title: Clinical pharmacokinetics of docetaxel
  publication-title: Clin. Pharmacokinet.
  doi: 10.2165/00003088-199936020-00002
  contributor:
    fullname: Clarke
– volume: 9
  start-page: 771
  year: 2008
  ident: 10.1016/j.jconrel.2010.08.006_bb0060
  article-title: Nanoparticle therapeutics: an emerging treatment modality for cancer
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2614
  contributor:
    fullname: Davis
SSID ssj0005347
Score 2.298327
Snippet In this paper we have investigated the behavior of core-shell poly(ethylene oxide)-poly(epsilon-caprolactone) (PEO-PCL) micelles derived from copolymers with...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 255
SubjectTerms Antineoplastic Agents - chemistry
Antineoplastic Agents - metabolism
Antineoplastic Agents - pharmacology
Biological and medical sciences
Biological Transport
Breast Neoplasms - metabolism
Breast Neoplasms - pathology
Cell Line, Tumor
Cell Proliferation - drug effects
Chemistry, Pharmaceutical
Cytotoxicity
Delayed-Action Preparations
Docetaxel
Dose-Response Relationship, Drug
Drug Carriers
Drug Compounding
Drug Stability
Female
General pharmacology
Humans
Inhibitory Concentration 50
Kinetics
Male
Medical sciences
Micelles
Nanoparticles
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Poly(ethylene oxide)-poly(epsilon-caprolactone)
Polyesters - chemistry
Polyesters - metabolism
Prostatic Neoplasms - metabolism
Prostatic Neoplasms - pathology
Solubility
Stability
Taxoids - chemistry
Taxoids - metabolism
Taxoids - pharmacology
Title In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
URI https://dx.doi.org/10.1016/j.jconrel.2010.08.006
https://www.ncbi.nlm.nih.gov/pubmed/20816710
https://search.proquest.com/docview/954590245
Volume 148
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBXp5lIopd_dpF3mUEID8e7alhy7lxLShk0LIdAEcjOyNabeGtvYTshe-of6Jzvjj5gcQqEXHwSyZY0079mamSfEB4I4Ow5cZWFie_SBohIrIGJiGeMbPsaRcdQGyJ55q0v57UpdbYnjIReGwyp739_59NZb9y2LfjYXZZoufhBZ8V1PBXaLm1z6c5vu7vgTsX10-n11NkZ6uLLLmvZ8izuMiTyL9XxNn50VZn2QFwdWeg9B1JNS1zRxSad48TAlbaHp5Jl42nNKOOqG_VxsYf5C7J13Rak3B3Ax5ljVB7AH52O56s1L8ec0h5u0qQqgSWanGGMFnO7AqhJQJGAI4hp9i5mVFdqgAVawzzKsgSHQQJFDWWSbj0g2JwxDKG5Tg_tW11jWaVbkVqzpNTIW98lxHyKC0F8Qs0DDhn-cf4IvBeQ6J2CtWEIPSj4jqLjYK_zUNwgaOAzy8ytxefL14nhl9RIOVkzQ31hq6bHVXYkyCgwiEvzZmBCJPKTroebydlxwxg5UIt1Wp92NlJTGMdJbRtJ9LSY5DeytAN9Xka0T4jtJLAM_0Zr8ESqk_kEU-2Yq5oPVwrKr1BEOIWzrsDdzyGYOWXhz6U2FP9g2vLfkQkKTf3Wd3VsLdw90XMUnzc5UwLA4QtqvbBWdY3FdhwFR1oDPu6fiTbdoxs4sgkKMb-f_B7YrHjt38TbvxKSprvE9saYmmolH89_2rN8bfwHr4Bom
link.rule.ids 315,783,787,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBUhObRQSr-7SZvOoYQG4ux6LTtWLyWkDbtNugS6gdyMbI2pt8Y2thOyv6l_sjP-iMkhFHrxQSAsa6R5T9bMPCE-EsTZkXJcC2PbowOKG1uKiIlljG_4GkdGYRMgu_Bml_L7lXu1IU76XBgOq-x8f-vTG2_dtYy72RwXSTL-SWTFdzxX2Q1ucunPLWIDinbn1vH8bLYYIj0c2WZNe77FHYZEnvHqcEXHzhLTLsiLAyu9hyDqSaErmri4Vbx4mJI20HT6TDztOCUct8N-LjYweyH2Ltqi1OsDWA45VtUB7MHFUK56_VL8mWdwk9RlDjTJ7BQjLIHTHVhVAvIYDEFcrW8xtdJcGzTACvZpihUwBBrIMyjydP0JyeaEYQj5bWJw32obiypJ88yKNH1GyuI-Ge5DSBD6GyIWaFjzj_PP8DWHTGcErCVL6EHBdwQlF3uFX_oGQQOHQX55JS5Pvy1PZlYn4WBFBP215U48trojUYbKICLBn40xkcgjeh5pLm_HBWds5cbSaXTandCV0kyN9CahdF6LzYwG9laA77uhrWPiO3EklR9rTf4IXaT-Kox8MxKHvdWCoq3UEfQhbKugM3PAZg5YeHPijYTf2za4t-QCQpN_dd29txbuXjh1XL5pno4E9IsjoP3KVtEZ5tdVoIiyKr7vHok37aIZOrMICjG-7f8f2AfxaLb8cR6czxdnO-Lx9C725p3YrMtrfE8Mqg53ux3yF7uGHBo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+vitro+anticancer+activity+of+docetaxel-loaded+micelles+based+on+poly%28ethylene+oxide%29-poly%28epsilon-caprolactone%29+block+copolymers%3A+Do+nanocarrier+properties+have+a+role%3F&rft.jtitle=Journal+of+controlled+release&rft.au=Ostacolo%2C+Luisanna&rft.au=Marra%2C+Monica&rft.au=Ungaro%2C+Francesca&rft.au=Zappavigna%2C+Silvia&rft.date=2010-12-01&rft.issn=0168-3659&rft.volume=148&rft.issue=2&rft.spage=255&rft.epage=263&rft_id=info:doi/10.1016%2Fj.jconrel.2010.08.006&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-3659&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-3659&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-3659&client=summon